Microorganism for genetic therapeutic treatment of proliferative diseases

Details for Australian Patent Application No. 2003206663 (hide)

Owner Zentaris GmbH

Inventors Goebel, Werner; Sedlacek, Hans-Harald; Fensterle, Joachim; Rapp, R Ulf; GENTSCHEV, Ivaylo

Agent Davies Collison Cave

Pub. Number AU-B-2003206663

PCT Number PCT/DE03/00470

PCT Pub. Number WO2003/068954

Priority 102 06 325.7 14.02.02 DE

Filing date 13 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 1 November 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/765 (2006.01) Peptides having more than 20 amino acids

C12N 1/00 (2006.01) Micro-organisms, e.g. protozoa

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 102 06 325.7 14.02.02 DE

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003206663

17 March 2005 Assignment before Grant

  Medinnova Gesellschaft Fur Medizinische Innovationen Aus Akademischer Forschung MbH The application has been assigned to Ulf R. Rapp

21 July 2005 Assignment before Grant

  Ulf R. Rapp The application has been assigned to Zentaris GmbH

1 November 2007 Application Accepted

  Published as AU-B-2003206663

6 March 2008 Standard Patent Sealed

10 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003206664-MICROORGANISMS AS CARRIERS OF NUCLEOTIDE SEQUENCES CODING FOR CELL ANTIGENS USED FOR THE TREATMENT OF TUMORS

2003206662-METHOD FOR THE DETECTION OF DAMAGE TO SPACECRAFT CAUSED BY THE IMPACT OF FOREIGN BODIES